Ribosomal proteins as distinct “passengers” of microvesicles: new semantics in myeloma and mesenchymal stem cells' communication
- 1 October 2021
- journal article
- research article
- Published by Elsevier in Translational Research
- Vol. 236, 117-132
Abstract
No abstract availableKeywords
Funding Information
- Israel Cancer Association (281100124)
- Varda and Boaz Dotan Research Center for Hemato-Oncology Research, Tel Aviv University (0601243683)
- Sackler Faculty of Medicine, Tel-Aviv University
- Tel Aviv University
This publication has 59 references indexed in Scilit:
- The emerging importance of ribosomal dysfunction in the pathogenesis of hematologic disordersLeukemia & Lymphoma, 2013
- WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013Nucleic Acids Research, 2013
- Myeloma Is Characterized by Stage-Specific Alterations in DNA Methylation That Occur Early during MyelomagenesisThe Journal of Immunology, 2013
- BM mesenchymal stromal cell–derived exosomes facilitate multiple myeloma progressionJournal of Clinical Investigation, 2013
- Preclinical activity of a novel CRM1 inhibitor in acute myeloid leukemiaBlood, 2012
- The genetic architecture of multiple myelomaNature Reviews Cancer, 2012
- ToppGene Suite for gene list enrichment analysis and candidate gene prioritizationNucleic Acids Research, 2009
- GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene listsBMC Bioinformatics, 2009
- The selectivity of protein kinase inhibitors: a further updateBiochemical Journal, 2007
- BI-D1870 is a specific inhibitor of the p90 RSK (ribosomal S6 kinase) isoformsin vitroandin vivoBiochemical Journal, 2006